Search results
Results From The WOW.Com Content Network
IQVIA, formerly Quintiles and IMS Health, Inc., [6] is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I ...
Xiamen Innovax Biotech. Xiamen Innovax Biotech CO., LTD. (Innovax) is a Chinese company that manufactures, markets, and develops vaccines. It is headquartered in Xiamen, Fujian, China. [1] [2]
Website. www .ipca .com. Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p- bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. [6] It produces more than 150 formulations that include oral ...
July 2, 2024 at 10:05 AM. (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had warned a website called ozempen.com against unlawfully selling versions of Novo Nordisk's weight ...
The Ortho-McNeil Pharmaceutical was formed from the merger of Ortho Pharmaceutical and McNeil Pharmaceutical in 1993. Both of these pharmaceutical companies are pioneers and leaders in areas such as pain management, acid reflux disease, and infectious diseases. Ortho-McNeil and Janssen Pharmaceutica together compose the Ortho-McNeil-Janssen ...
Website. www .actavis .com. Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Headquarters. Cambridge, Massachusetts. , United States. Website. cerevel .com. Cerevel Therapeutics Holdings, Inc. is a biotechnology and pharmaceuticals company focused on the development of novel therapies for mental and neurological illnesses. [1] Cerevel was established in October 2018, and is headquartered in Cambridge, Massachusetts.
Girentuximab. Girentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). [1] CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. [2]